Capricor Therapeutics's total assets for Q3 2024 were $92.95M, an increase of 142.84% from the previous quarter. CAPR total liabilities were $24.69M for the fiscal quarter, a -7.80% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.